Follow
James A. D. Good
James A. D. Good
Principal Scientist, Pfizer
No verified email - Homepage
Title
Cited by
Cited by
Year
Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system
MG Varga, CL Shaffer, JC Sierra, G Suarez, MB Piazuelo, ME Whitaker, ...
Oncogene 35 (48), 6262-6269, 2016
1182016
Adhesive Fiber Stratification in Uropathogenic Escherichia coli Biofilms Unveils Oxygen-Mediated Control of Type 1 Pili
KA Floyd, JL Moore, AR Eberly, JAD Good, CL Shaffer, H Zaver, ...
PLoS Pathogens 11 (3), 2015
992015
Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activity
F Wang, JAD Good, O Rath, HYK Kaan, OB Sutcliffe, SP Mackay, ...
Journal of Medicinal Chemistry 55 (4), 1511-1525, 2012
742012
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
K Flentie, GA Harrison, H Tükenmez, J Livny, JAD Good, S Sarkar, ...
Proceedings of the National Academy of Sciences 116 (21), 10510-10517, 2019
552019
Thiazolino 2-pyridone amide inhibitors of Chlamydia trachomatis infectivity
JAD Good, J Silver, C Núñez-Otero, W Bahnan, KS Krishnan, O Salin, ...
Journal of Medicinal Chemistry 59 (5), 2094-2108, 2016
542016
State of the Art in Respiratory Syncytial Virus Drug Discovery and Development
GS Cockerill, JAD Good, N Mathews
Journal of Medicinal Chemistry 62 (7), 3206-3227, 2018
532018
Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens
CL Shaffer, JAD Good, S Kumar, KS Krishnan, JA Gaddy, JT Loh, ...
mBio 7 (2), e00221-16, 2016
492016
Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models
JAD Good, F Wang, O Rath, HYK Kaan, SK Talapatra, D Podgórski, ...
Journal of Medicinal Chemistry 56 (5), 1878-1893, 2013
472013
Attenuating Listeria monocytogenes Virulence by Targeting the Regulatory Protein PrfA
JAD Good, C Andersson, S Hansen, J Wall, KS Krishnan, A Begum, ...
Cell Chemical Biology 23 (3), 404-14, 2016
352016
Elucidating the functionality of kinesins: An overview of small molecule inhibitors
JAD Good, DA Skoufias, F Kozielski
Seminars in cell & developmental biology 22 (9), 935-945, 2011
342011
Thiazolino 2-pyridone amide isosteres as inhibitors of Chlamydia trachomatis infectivity
JAD Good, M Kulén, J Silver, KS Krishnan, W Bahnan, C Núñez-Otero, ...
Journal of Medicinal Chemistry 60 (22), 9393-9399, 2017
282017
Doing the methylene shuffle–Further insights into the inhibition of mitotic kinesin Eg5 with S-trityl l-cysteine
MN Abualhasan, JAD Good, K Wittayanarakul, NG Anthony, G Berretta, ...
European journal of medicinal chemistry 54, 483-498, 2012
272012
Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion
GS Cockerill, RM Angell, A Bedernjak, I Chuckowree, I Fraser, ...
Journal of Medicinal Chemistry 64 (7), 3658-3676, 2021
242021
Nitrones for understanding and ameliorating the oxidative stress associated with aging
S El Fangour, M Marini, J Good, SJ McQuaker, PG Shiels, RC Hartley
Age 31, 269-276, 2009
152009
Synthesis of fluorescent ring-fused 2-pyridone peptidomimetics
KS Krishnan, C Bengtsson, JAD Good, S Mirkhanov, E Chorell, ...
The Journal of Organic Chemistry 78 (23), 12207-12213, 2013
112013
Synthesis of a solid-phase amino imidazotriazine library via palladium catalyzed direct arylation
S Maechling, J Good, SD Lindell
Journal of combinatorial chemistry 12 (6), 818-821, 2010
82010
Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors
M Kulén, C Núñez-Otero, AG Cairns, J Silver, AEG Lindgren, E Wede, ...
MedChemComm 10 (11), 1966-1987, 2019
62019
Design, Synthesis, and Evaluation of Novel Δ2-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant
S Sarkar, AE Mayer Bridwell, JAD Good, ER Wang, SR McKee, J Valenta, ...
Journal of Medicinal Chemistry 66 (16), 11056-11077, 2023
42023
WO 2016/075296 2,3-Dihydro-thiazolo[3,2-a]pyridin-5-one Derivatives, Intermediates Thereof, And Their Use As Antibacterial Agents
JAD Good, AM Kulén, KF Almqvist, AG Cairns, JF Pontén
WO Patent WO/2016/075,296, 2016
4*2016
The Discovery and Development of Eg5 Inhibitors for the Clinic
JAD Good, G Berretta, NG Anthony, SP Mackay
Kinesins and Cancer, 27-52, 2015
42015
The system can't perform the operation now. Try again later.
Articles 1–20